爱尔兰爵士制药的defiteli一支的价格

Defibrotide () is an adenosine receptor agonist with multiple effects. It can reduce the expression of cell adhesion molecules on the surface of endothelial cells, thereby reducing the adhesion of leukocytes to vascular endothelial cells and reducing the inflammatory damage of endothelial cells.

On October 22, 2013, defibrotide (defiteli) was approved for marketing by the European Union as the first treatment for severe hepatic veno-occlusive disease in adults and children undergoing hematopoietic stem cell transplantation. On March 30, 2016, the U.S. Food and Drug Administration (FDA) approved defiteli for the treatment of hepatic veno-occlusive disease (VOD) caused by hematopoietic stem cell transplantation in adults and children with renal and pulmonary dysfunction. Defibrotide (defiteli) is the first and only drug for the treatment of severe hepatic veno-occlusive disease.

Jazz Pharmaceuticals Public Limited Company (NASDAQ: JAZZ) was founded in 2003 and is headquartered in Dublin, Ireland. It has 1,620 full-time employees. It is a commercial-stage biopharmaceutical company. Defiteli is developed and produced by Jazz Pharmaceuticals in Ireland. What is the price of one defiteli pill from Jazz Pharmaceuticals in Ireland?

The specification of Irish Jazz Pharmaceuticals plc is 200 mg, and the price of one tube is about $21,600.

Recommended related hot articles: /newsDetail/95230.html

  Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.